Accepting your first post-training job is a big decision that can affect the trajectory of your career. Any reasonable employer recognizes the gravity of this decision for a young professional and should welcome and expect some reasonable degree of negotiation and discussion before finalizing acceptance of an offer.
Issue Edited by: William L. Baker, Cynthia A. Jackevicius
Cardiovascular disease is the leading health burden in the United States, contributing significantly to morbidity and mortality. Guest editors William L. Baker and Cynthia A. Jackevicius provide valuable insight into recent advances in cardiovascular pharmacotherapy
The 2021 ACCP Certification Affairs Committee has developed this commentary to describe key differences between remote and on-site experiential education including an essential resources and rotation structure.
As an African American man raised in inner-city Philadelphia, Allen is familiar with the challenges often faced by people from underserved communities. For him and those who grow up in medically underserved communities, health disparities are a vivid reality, and these experiences have shaped his professional identity.
One strategy to reduce health disparities, according to Ferraro, is to increase awareness of the health disparities that affect the community: "I seek opportunities to respectfully bring awareness to the issues that impact the community I serve so that it may bring about conversations in others. I cannot speak for the community, but I can share what I know to address disparities and the impacts these disparities have on patient outcomes."
The Federal COVID Response (FCR) Therapeutics Team, under the U.S. Department of Health and Human Services, provides resources to support rapid access to monoclonal antibody (mAb) treatment for high-risk COVID-19 patients.
Joseph M. LaRochelle, Pharm.D., FCCP, BCPPS, is the Coleman Endowed Professor of Pharmacy Practice and vice chair of the Division of Clinical and Administrative Sciences at Xavier University of Louisiana.
This white paper evaluates the current and future state of clinical pharmacist-led precision medicine initiatives, focusing on an overview of pharmacogenomics (PGx) in three key areas: clinical practice, education, and research.
In pharmacy education, we are experiencing the “new normal” after an “inflection point” along with a host of other overused phrases. Yet, without doubt, there is pressing need to reconsider what was once standard operating procedure.
Millions of consumers have chosen to pursue direct-to-consumer (DTC) genetic testing for personal health-related and/or non-health-related information. However, genetic test results can be complex to interpret, and the regulatory landscape for DTC genetic tests is in flux.
Madison L. Adams graduated from the University of Pittsburgh School of Pharmacy with a Pharm.D. degree in 2017, after which she entered the U.S. Public Health Service and pursued a PGY1 pharmacy practice residency with the Indian Health Service (IHS) at the Northern Navajo Medical Center (NNMC).
Jennifer N. Clements Pharm.D., FCCP Roshni P. Emmons Pharm.D. Sarah L. Anderson Pharm.D., FCCP Marissa Chow Pharm.D. Candidate Scott Coon Pharm.D. Adriane N. Irwin Pharm.D. S. Mimi Mukherjee Pharm.D. Julie M. Sease Pharm.D., FCCP Kim Thrasher Phar
Given the decade of changes and advances in ambulatory care (AC) practice since the 2011 publication, the 2020 ACCP Publications Committee has developed the present white paper to update quality metrics and provide performance indicators with proposed guidance for CMM in AC practice.
The coronavirus disease 2019 (COVID‐19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 has challenged health systems to find innovative ways of delivering patient care while protecting staff from infection with the virus.